Séverine Vermeire

Prof. Séverine Vermeire obtained her MD and PhD at KU Leuven and has also trained at the National University of Asuncion, Paraguay, the Wellcome Centre for Human Genetics, UK, and Montreal General Hospital, Canada. Since 2003, she has been a staff member at the Gastroenterology Department of University Hospitals Leuven and is Professor of Medicine at KU Leuven, becoming Head of the Department of Chronic Diseases and Metabolism in 2016. Prof. Vermeire has been a principal investigator in several randomised controlled trials with new therapeutic compounds. Her work, which focuses on the role of the microbiome, genetic susceptibility in IBD and signatures predictive of therapy response, has led to over 500 peer-reviewed articles.